Claire Hourrègue

1.6k total citations
25 papers, 354 citations indexed

About

Claire Hourrègue is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Claire Hourrègue has authored 25 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 15 papers in Psychiatry and Mental health and 7 papers in Neurology. Recurrent topics in Claire Hourrègue's work include Alzheimer's disease research and treatments (14 papers), Dementia and Cognitive Impairment Research (14 papers) and Neuroscience and Neuropharmacology Research (3 papers). Claire Hourrègue is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Dementia and Cognitive Impairment Research (14 papers) and Neuroscience and Neuropharmacology Research (3 papers). Claire Hourrègue collaborates with scholars based in France, United Kingdom and Sweden. Claire Hourrègue's co-authors include Claire Paquet, Julien Dumurgier, Agathe Vrillon, Emmanuel Cognat, Kaj Blennow, Henrik Zetterberg, Jacques Hugon, Élodie Bouaziz-Amar, Matthieu Lilamand and François Mouton‐Liger and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Claire Hourrègue

22 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Hourrègue France 11 189 122 99 74 57 25 354
Agathe Vrillon France 12 218 1.2× 140 1.1× 109 1.1× 81 1.1× 63 1.1× 32 409
Naomi De Roeck Belgium 9 137 0.7× 88 0.7× 75 0.8× 109 1.5× 57 1.0× 13 341
David Just Sweden 11 102 0.5× 50 0.4× 90 0.9× 141 1.9× 27 0.5× 17 379
Furu Liang China 5 173 0.9× 98 0.8× 42 0.4× 268 3.6× 103 1.8× 9 508
Alejandro Herrero-San Martín Spain 5 78 0.4× 49 0.4× 43 0.4× 58 0.8× 25 0.4× 7 209
Przemysław R. Kac Sweden 9 274 1.4× 190 1.6× 68 0.7× 106 1.4× 69 1.2× 19 446
Harli Grant United States 7 146 0.8× 118 1.0× 92 0.9× 58 0.8× 46 0.8× 12 307
Khaled Abdallah Canada 11 79 0.4× 42 0.3× 99 1.0× 100 1.4× 21 0.4× 18 337
Rachel L. Henson United States 11 157 0.8× 110 0.9× 87 0.9× 88 1.2× 59 1.0× 20 324
Kaj Blennow Sweden 7 95 0.5× 66 0.5× 32 0.3× 59 0.8× 34 0.6× 50 239

Countries citing papers authored by Claire Hourrègue

Since Specialization
Citations

This map shows the geographic impact of Claire Hourrègue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Hourrègue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Hourrègue more than expected).

Fields of papers citing papers by Claire Hourrègue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Hourrègue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Hourrègue. The network helps show where Claire Hourrègue may publish in the future.

Co-authorship network of co-authors of Claire Hourrègue

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Hourrègue. A scholar is included among the top collaborators of Claire Hourrègue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Hourrègue. Claire Hourrègue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumurgier, Julien, Claire Paquet, Jacques Hugon, et al.. (2025). MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study. The Journal of Prevention of Alzheimer s Disease. 12(3). 100077–100077.
2.
Bouaziz-Amar, Élodie, Fidaa Ibrahim, Matthieu Martinet, et al.. (2025). Cerebrospinal fluid leptin in Alzheimer’s disease: relationship to plasma levels and to cerebrospinal amyloid. Clinical Chemistry and Laboratory Medicine (CCLM). 63(12). 2460–2467.
3.
Dumurgier, Julien, et al.. (2024). Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder. International Journal of Bipolar Disorders. 12(1). 45–45. 1 indexed citations
4.
Vrillon, Agathe, Olivier Bousiges, Catherine Demuynck, et al.. (2024). Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies. Alzheimer s Research & Therapy. 16(1). 146–146. 8 indexed citations
5.
Vrillon, Agathe, Julien Dumurgier, Sandrine Indart, et al.. (2024). Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study. Alzheimer s Research & Therapy. 16(1). 231–231. 8 indexed citations
6.
Wallon, David, Bertrand Degos, Alexandre Obadia, et al.. (2023). Is the clinical phenotype impact the prognosis in dementia with Lewy bodies?. Alzheimer s Research & Therapy. 15(1). 169–169.
7.
Vrillon, Agathe, François Mouton‐Liger, Matthieu Martinet, et al.. (2023). Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease. Alzheimer s & Dementia. 19(S2). 1 indexed citations
8.
Camporesi, Elena, Johanna Nilsson, Agathe Vrillon, et al.. (2022). Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry. EBioMedicine. 75. 103793–103793. 5 indexed citations
9.
Lilamand, Matthieu, Élodie Bouaziz-Amar, Julien Dumurgier, et al.. (2022). Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients. The Journals of Gerontology Series A. 78(4). 645–652. 14 indexed citations
10.
Vrillon, Agathe, François Mouton‐Liger, Matthieu Martinet, et al.. (2022). Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study. Alzheimer s Research & Therapy. 14(1). 71–71. 26 indexed citations
11.
Vrillon, Agathe, Élodie Bouaziz-Amar, François Mouton‐Liger, et al.. (2022). Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study. Neurobiology of Disease. 176. 105937–105937. 14 indexed citations
12.
Gaubert, Sinead, Claire Hourrègue, François Mouton‐Liger, et al.. (2022). Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review. Neuroscience & Biobehavioral Reviews. 141. 104856–104856. 14 indexed citations
13.
Hugon, J, Claire Hourrègue, Emmanuel Cognat, et al.. (2021). Chronic traumatic encephalopathy. Neurochirurgie. 67(3). 290–294. 10 indexed citations
14.
Rabuel, Christophe, et al.. (2021). Determinants of Post-Operative Cognitive Decline in Elderly People. The Journal of Prevention of Alzheimer s Disease. 8(3). 322–328. 5 indexed citations
15.
Vrillon, Agathe, et al.. (2021). COVID-19 in adults with dementia: clinical features and risk factors of mortality—a clinical cohort study on 125 patients. Alzheimer s Research & Therapy. 13(1). 77–77. 21 indexed citations
16.
Lilamand, Matthieu, Claire Hourrègue, & Claire Paquet. (2020). Interest of biological biomarkers in the diagnostic approach of neurocognitive disorders in the elderly. Revue Neurologique. 176(9). 677–683. 9 indexed citations
17.
Karikari, Thomas K., Andreja Emeršič, Agathe Vrillon, et al.. (2020). Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis. Alzheimer s & Dementia. 17(5). 755–767. 95 indexed citations
18.
Mouton‐Liger, François, Julien Dumurgier, Emmanuel Cognat, et al.. (2020). CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease. Alzheimer s Research & Therapy. 12(1). 88–88. 30 indexed citations
19.
Cognat, Emmanuel, Sèverine Sabia, Claire Hourrègue, et al.. (2019). CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease. Alzheimer s Research & Therapy. 11(1). 29–29. 22 indexed citations
20.
Cognat, Emmanuel, Sèverine Sabia, Claire Hourrègue, et al.. (2019). Biomarker profiles of Alzheimer’s disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau. PLoS ONE. 14(5). e0217026–e0217026. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agathe Vrillon Breakdown of academic impact, for papers by Naomi De Roeck Breakdown of academic impact, for papers by David Just Breakdown of academic impact, for papers by Furu Liang Breakdown of academic impact, for papers by Alejandro Herrero-San Martín Breakdown of academic impact, for papers by Przemysław R. Kac Breakdown of academic impact, for papers by Harli Grant Breakdown of academic impact, for papers by Khaled Abdallah Breakdown of academic impact, for papers by Rachel L. Henson Breakdown of academic impact, for papers by Kaj Blennow
Rankless by CCL
2026